Holen Sie sich die Stockscreener-App
58.63
0.60%
-0.3756
Schlusskurs vom Vortag:
$59.01
Offen:
$59.16
24-Stunden-Volumen:
1.03M
Relative Volume:
0.74
Marktkapitalisierung:
$9.54B
Einnahmen:
$2.48B
Nettoeinkommen (Verlust:
$91.51M
KGV:
87.51
EPS:
0.67
Netto-Cashflow:
$293.77M
1W Leistung:
-16.72%
1M Leistung:
-19.20%
6M Leistung:
-28.94%
1J Leistung:
-7.99%
1-Tages-Spanne:
$57.82
$59.48
1-Wochen-Bereich:
$54.48
$73.05
52-Wochen-Spanne:
$54.48
$94.93
Globus Medical Inc Stock (GMED) Company Profile
Firmenname
Globus Medical Inc
Sektor
Branche
Telefon
610-930-1800
Adresse
2560 GENERAL ARMISTEAD AVENUE, AUDUBON, PA
Vergleichen Sie GMED mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GMED
Globus Medical Inc
|
58.65 | 9.54B | 2.48B | 91.51M | 293.77M | 0.67 |
|
ABT
Abbott Laboratories
|
129.47 | 230.70B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
103.42 | 154.22B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
388.90 | 145.74B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
85.35 | 107.03B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
75.18 | 44.06B | 5.54B | 4.18B | 623.10M | 7.00 |
Globus Medical Inc Stock (GMED) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-10 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2024-12-02 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-08-07 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-05-20 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2024-03-18 | Hochstufung | BTIG Research | Neutral → Buy |
| 2023-10-20 | Eingeleitet | ROTH MKM | Buy |
| 2023-09-19 | Hochstufung | Stifel | Hold → Buy |
| 2023-03-30 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2023-02-13 | Herabstufung | BofA Securities | Buy → Underperform |
| 2023-02-10 | Herabstufung | BTIG Research | Buy → Neutral |
| 2023-02-10 | Herabstufung | Loop Capital | Buy → Hold |
| 2023-02-10 | Herabstufung | Needham | Buy → Hold |
| 2023-02-10 | Herabstufung | Truist | Buy → Hold |
| 2023-02-10 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-10-18 | Eingeleitet | Barclays | Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2022-04-13 | Fortgesetzt | Truist | Buy |
| 2022-03-28 | Eingeleitet | Wells Fargo | Overweight |
| 2022-01-04 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2021-12-13 | Hochstufung | BofA Securities | Underperform → Buy |
| 2021-12-10 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-10-29 | Eingeleitet | Loop Capital | Buy |
| 2021-02-18 | Fortgesetzt | Needham | Buy |
| 2020-12-08 | Eingeleitet | Citigroup | Buy |
| 2020-10-20 | Eingeleitet | Stifel | Hold |
| 2020-08-06 | Bestätigt | Needham | Buy |
| 2020-08-06 | Hochstufung | Northland Capital | Market Perform → Outperform |
| 2020-07-21 | Eingeleitet | Northland Capital | Market Perform |
| 2020-07-06 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2020-05-08 | Bestätigt | Needham | Buy |
| 2020-03-18 | Hochstufung | BTIG Research | Neutral → Buy |
| 2020-01-08 | Eingeleitet | SunTrust | Buy |
| 2019-12-12 | Hochstufung | Wells Fargo | Market Perform → Outperform |
| 2019-08-02 | Bestätigt | Needham | Buy |
| 2019-05-24 | Herabstufung | Wells Fargo | Outperform → Market Perform |
| 2019-05-03 | Bestätigt | Needham | Buy |
| 2019-02-28 | Hochstufung | UBS | Neutral → Buy |
| 2019-01-02 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2018-08-02 | Bestätigt | Needham | Buy |
| 2018-06-27 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2018-06-01 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2018-05-03 | Bestätigt | Needham | Buy |
| 2018-04-04 | Hochstufung | Needham | Hold → Buy |
Alle ansehen
Globus Medical Inc Aktie (GMED) Neueste Nachrichten
Morgan Stanley Adjusts Price Target on Globus Medical to $75 From $100, Maintains Overweight Rating - marketscreener.com
Globus closes down 23% as earnings misses, lowered EPS guidance weigh - MSN
GMED Stock Update: Truist Securities Lowers Price Target | GMED - GuruFocus
Solventum, Envista, ICU Medical, Globus Medical, and Enovis Stocks Trade Up, What You Need To Know - FinancialContent
Globus Medical (GMED) Faces Price Target Reduction Amid Earnings - GuruFocus
GMED Q1 Earnings & Revenues Miss, '25 EPS View Down, Stock Falls - TradingView
Globus medical outlines $2.8B-$2.9B 2025 revenue guidance amid Nevro integration - MSN
Globus Medical, Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now - simplywall.st
Globus Medical, Inc. Just Missed EarningsBut Analysts Have Updated Their Models - Yahoo Finance
Globus Medical, Inc. (NYSE:GMED) Q1 2025 Earnings Call Transcript - Insider Monkey
Globus Medical (GMED) Stock Plummets After Q1 Earnings Miss - GuruFocus
Globus Medical (GMED) Price Target Lowered to $80 by Piper Sandl - GuruFocus
Globus Medical (GMED) Target Price Adjusted by RBC Capital | GME - GuruFocus
Globus Medical stock target cut to $78 by Oppenheimer - Investing.com South Africa
Globus closes down 23% as earnings misses, lowered EPS guidance weigh (GMED:NYSE) - Seeking Alpha
A Glimpse Into The Expert Outlook On Globus Medical Through 6 Analysts - Benzinga
Truist cuts Globus Medical stock target to $68, maintains hold By Investing.com - Investing.com Canada
Globus Medical stock down on Q1 miss, reduced EPS guidance - MassDevice
Globus Medical (GMED) Price Target Reduced by Stifel | GMED Stock News - GuruFocus
Globus Medical (GMED) Price Target Lowered to $80 by Piper Sandler | GMED Stock News - GuruFocus
Globus Medical (GMED) Target Price Adjusted by RBC Capital | GMED Stock News - GuruFocus
Truist Securities Adjusts Globus Medical Price Target to $68 From $80, Maintains Hold Rating - marketscreener.com
Globus Medical (GMED) Faces Price Target Reduction Amid Q1 Strug - GuruFocus
Globus Medical (GMED) Sees Price Target Cut Amid Q1 Challenges | GMED Stock News - GuruFocus
Globus Medical (GMED) Faces Price Target Reduction Amid Q1 Challenges | GMED Stock News - GuruFocus
Globus Medical sales decrease 1.4% to USD 598.1M in Q1 2025 - Medical Buyer
Globus Medical Reports Mixed Q1 2025 Results, Sets Positive Revenue GuidanceNews and Statistics - IndexBox
Globus Medical Reports Q1 2025 Financial Results - TipRanks
Globus Medical Inc (GMED) Q1 2025 Earnings Call Highlights: Navigating Challenges with ... - Yahoo Finance
Globus Medical: Q1 Earnings Snapshot - Norwalk Hour
Globus Medical Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Globus Medical (GMED) Reports Q1 Earnings: What Key Metrics Have to Say - Yahoo Finance
Globus Medical (GMED) Lags Q1 Earnings and Revenue Estimates - Yahoo Finance
GLOBUS MEDICAL INC SEC 10-Q Report - TradingView
Globus Medical Inc Q1 2025 Earnings: EPS of $0.54 Misses Estimat - GuruFocus
Globus Medical Reports First Quarter 2025 Results | GMED Stock N - GuruFocus
Globus Medical (NYSE:GMED) Reports Sales Below Analyst Estimates In Q1 Earnings, Stock Drops 17.1% - Yahoo Finance
Globus Medical Q1 Non-GAAP Earnings Rise, Sales Decline -- Shares Fall After Hours - marketscreener.com
Globus Medical Reports First Quarter 2025 Results | GMED Stock News - GuruFocus
Globus Medical Inc Q1 2025 Earnings: EPS of $0.54 Misses Estimates, Revenue at $598.1 Million Falls Short - GuruFocus
Globus Medical Reports First Quarter 2025 Results - GlobeNewswire
Earnings To Watch: Globus Medical (GMED) Reports Q1 Results Tomorrow - Yahoo Finance
What Does Globus Medical, Inc.'s (NYSE:GMED) Share Price Indicate? - Yahoo Finance
At US$71.91, Is It Time To Put Globus Medical, Inc. (NYSE:GMED) On Your Watch List? - simplywall.st
Gear Up for Globus Medical (GMED) Q1 Earnings: Wall Street Estimates for Key Metrics - Yahoo Finance
Interspinous Spacers Market Analysis: Data-Driven Insights - openPR.com
Globus Medical (GMED) Earnings Expected to Grow: Should You Buy? - Yahoo Finance
4 MedTech Stocks Poised to Outshine Q1 Earnings Estimates - TradingView
BlackRock, Inc. Adjusts Stake in Globus Medical Inc - GuruFocus
Press Release Distribution & PR Platform - ACCESS Newswire
What Does the Market Think About Globus Medical?Globus Medical (NYSE:GMED) - Benzinga
Finanzdaten der Globus Medical Inc-Aktie (GMED)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.27%
0.39%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):